New Key Statistics Module, Z-Score and F-Score
SZSE:301333 Key Ratios
Market Cap ¥ M | 4,422.45 |
Enterprise Value ¥ M | 2,897.67 |
P/E(ttm) | 27.75 |
PE Ratio without NRI | 28.32 |
Forward PE Ratio | 25.29 |
Price/Book | 2.48 |
Price/Sales | 5.46 |
Price/Free Cash Flow | 26.60 |
Price/Owner Earnings | 44.16 |
Payout Ratio % | 0.12 |
Revenue (TTM) ¥ M | 758.00 |
EPS (TTM) ¥ | 1.65 |
Beneish M-Score | -1.27 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 6.20 |
y-y EBITDA Growth Rate % | -16.40 |
EV-to-EBIT | 20.80 |
EV-to-EBITDA | 20.80 |
PEG | 4.57 |
Shares Outstanding M | 96.58 |
Net Margin (%) | 15.96 |
Operating Margin % | 14.51 |
Pre-tax Margin (%) | 18.01 |
Quick Ratio | 4.55 |
Current Ratio | 4.70 |
ROA % (ttm) | 5.59 |
ROE % (ttm) | 6.87 |
ROIC % (ttm) | 24.65 |
Dividend Yield % | 0.45 |
Altman Z-Score | 6.82 |
SZSE:301333 Number of Guru Trades
SZSE:301333 Volume of Guru Trades
Gurus Latest Trades with SZSE:301333
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301333 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
R&G PharmaStudies Co Ltd Insider Transactions
No Available Data